Key Decisions in HIV Care: Choosing Initial ART in PWH With Transmitted Drug Resistance

In this episode, John D. Baxter, MD, explores recommendations and data on choosing antiretroviral therapy with transmitted drug resistance.Listen as he gives his perspectives on:Initial response to antiretroviral therapy during primary HIV infection with baseline resistanceData from the START study on treatment-naive patients with transmitted drug resistance by region and drug classRecommendations from the US Department of Health and Human Services and International AIDS Society–USA guidelines on baseline genotype testing for integrase strand transfer inhibitor resistanceConsiderations for the use of second-generation integrase strand transfer inhibitors and darunavir with transmitted drug resistanceCases of transmitted multidrug-resistant HIV in patients receiving pre-exposure prophylaxisPresenter:John D. Baxter, MDProfessor of MedicineDivision of Infectious DiseasesDepartment of PathologyCooper Medical School of Rowan UniversityHead, Division of Infectious DiseasesCooper University Health CareCamden, New JerseyFollow along with the slides at:https://bit.ly/3u7pjWqSee the entire program at: https://bit.ly/3fOl0XX  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

There are no comments yet.

Please log in to write the first comment.